Qiagen NV Company Profile (NASDAQ:QGEN)

About Qiagen NV

Qiagen NV logoQIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to decide on further action. It offers solutions in molecular diagnostics, applied testing, pharma and academia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: QGEN
  • CUSIP: N7248210
Key Metrics:
  • Previous Close: $25.80
  • 50 Day Moving Average: $26.57
  • 200 Day Moving Average: $24.08
  • 52-Week Range: $234,000,000.00 - $19.94
  • Trailing P/E Ratio: 51.60
  • Foreward P/E Ratio: 20.98
  • P/E Growth: 2.57
  • Market Cap: $6.04B
  • Outstanding Shares: 234,000,000
  • Beta: 0.83
  • Net Margins: 9.13%
  • Return on Equity: 9.21%
  • Return on Assets: 5.74%
  • Debt-to-Equity Ratio: 0.41%
  • Current Ratio: 3.62%
  • Quick Ratio: 3.06%
Additional Links:
Companies Related to Qiagen NV:

Analyst Ratings

Consensus Ratings for Qiagen NV (NASDAQ:QGEN) (?)
Ratings Breakdown: 7 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $25.00 (3.10% downside)

Analysts' Ratings History for Qiagen NV (NASDAQ:QGEN)
DateFirmActionRatingPrice TargetDetails
9/19/2016DZ Bank AGReiterated RatingBuyView Rating Details
9/16/2016Commerzbank AGReiterated RatingBuyView Rating Details
9/11/2016Morgan StanleySet Price TargetBuy$30.00View Rating Details
8/4/2016Jefferies GroupReiterated RatingHoldView Rating Details
8/1/2016HSBCUpgradeHold -> BuyView Rating Details
8/1/2016MizuhoBoost Price TargetNeutral$22.00 -> $25.00View Rating Details
7/29/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
7/25/2016Piper Jaffray Cos.Reiterated RatingNeutral$23.00View Rating Details
6/6/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
3/15/2016Citigroup Inc.Lower Price TargetNeutral$28.00 -> $25.00View Rating Details
2/3/2016Barclays PLCLower Price TargetOverweight$28.00 -> $27.00View Rating Details
1/7/2016Cowen and CompanyBoost Price Target$24.00View Rating Details
11/12/2015Stifel NicolausInitiated CoverageHoldView Rating Details
10/30/2015Goldman Sachs Group Inc.Lower Price Target$22.00 -> $21.00View Rating Details
10/29/2015WedbushLower Price TargetNeutral$21.00 -> $20.00View Rating Details
5/28/2015Credit Suisse Group AGReiterated RatingNeutral$24.00 -> $25.00View Rating Details
1/6/2015Bank of America Corp.DowngradeNeutral -> Underperform$26.00 -> $24.00View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Qiagen NV (NASDAQ:QGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216$0.23$0.24$326.73 million$334.40 millionViewN/AView Earnings Details
4/27/2016Q116$0.19$0.19$295.76 million$298.40 millionViewN/AView Earnings Details
2/2/2016Q415$0.32$0.33$354.47 million$349.00 millionViewN/AView Earnings Details
10/28/2015Q315$0.28$0.27$323.50 million$314.60 millionViewListenView Earnings Details
7/29/2015Q215$0.25$0.26$319.43 million$319.50 millionViewListenView Earnings Details
5/7/2015Q115$0.22$0.22$304.60 million$298.70 millionViewN/AView Earnings Details
1/28/2015Q414$0.30$0.25$367.82 million$360.80 millionViewN/AView Earnings Details
10/29/2014Q3$0.27$0.27$337.00 million$336.80 millionViewN/AView Earnings Details
7/29/2014Q214$0.25$0.26$330.76 million$331.20 millionViewN/AView Earnings Details
5/7/2014Q114$0.22$0.22$317.09 million$317.40 millionViewN/AView Earnings Details
1/29/2014Q413$0.34$0.36$365.52 million$362.60 millionViewN/AView Earnings Details
10/29/2013Q313$0.25$0.28$320.37 million$323.80 millionViewN/AView Earnings Details
7/30/2013Q213$0.24$0.27$311.75 million$316.40 millionViewN/AView Earnings Details
4/29/2013Q113$0.23$0.23$305.50 million$303.60 millionViewN/AView Earnings Details
1/29/2013Q412$0.31$0.34$327.80 million$346.50 millionViewN/AView Earnings Details
11/5/2012Q312$0.24$0.26$303.79 million$304.30 millionViewN/AView Earnings Details
7/24/2012$0.25$0.25ViewN/AView Earnings Details
4/25/2012$0.21$0.23ViewN/AView Earnings Details
1/31/2012$0.28$0.31ViewN/AView Earnings Details
11/2/2011$0.22$0.24ViewN/AView Earnings Details
7/25/2011$0.23$0.23ViewN/AView Earnings Details
4/27/2011$0.21$0.21ViewN/AView Earnings Details
1/31/2011$0.25$0.26ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Qiagen NV (NASDAQ:QGEN)
Current Year EPS Consensus Estimate: $1.09 EPS
Next Year EPS Consensus Estimate: $1.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.19$0.25$0.22
Q2 20164$0.25$0.29$0.27
Q3 20164$0.27$0.30$0.29
Q4 20163$0.33$0.39$0.36
(Data provided by Zacks Investment Research)


Dividend History for Qiagen NV (NASDAQ:QGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Qiagen NV (NASDAQ:QGEN)
No insider trades for this company have been tracked by MarketBeat.com


Latest Headlines for Qiagen NV (NASDAQ:QGEN)
News IconMeag Munich Ergo Kapitalanlagegesellschaft MBH Sold shares of Qiagen NV (QGEN) - DailyQuint (NASDAQ:QGEN)
dailyquint.com - October 22 at 10:58 AM
publicnow.com logoQIAGEN launches QIAscout for single-cell isolation (NASDAQ:QGEN)
www.publicnow.com - October 20 at 7:15 PM
News IconWall Street Consensus Update & Stock Review on Qiagen NV (NASDAQ:QGEN) - Recall News (NASDAQ:QGEN)
www.automobile-recalls.net - October 20 at 8:25 AM
capitalcube.com logoETF’s with exposure to QIAGEN NV : October 19, 2016 (NASDAQ:QGEN)
www.capitalcube.com - October 19 at 3:33 PM
stocksdaily.net logoEPS Target Of Qiagen NV (NASDAQ:QGEN) At $0.28? - Stocks Daily (NASDAQ:QGEN)
www.stocksdaily.net - October 18 at 12:15 PM
News IconQiagen N.V. (NASDAQ:QGEN) Updated Broker Price Targets - The De Soto Edge (NASDAQ:QGEN)
www.desotoedge.com - October 18 at 12:15 PM
publicnow.com logoQIAGEN unveils unique Sample to Insight solutions for liquid biopsies and hereditary diseases (NASDAQ:QGEN)
www.publicnow.com - October 17 at 6:49 PM
News IconNeedle Moving as Stock Balloons in Quarter: Qiagen NV (NASDAQ:QGEN) - Recall News (NASDAQ:QGEN)
www.automobile-recalls.net - October 16 at 6:44 PM
realistinvestor.com logoQiagen NV (NASDAQ:QGEN) Deferred Tax Assets At $33.068 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - October 16 at 6:44 PM
News IconQiagen NV (NASDAQ:QGEN) To Report September 2016 Results - The Voice Registrar (NASDAQ:QGEN)
voiceregistrar.com - October 16 at 11:17 AM
News IconUpdate on Qiagen NV (NASDAQ:QGEN) for the day (NASDAQ:QGEN)
twincountynews.com - October 14 at 6:43 PM
News IconBargain-Counter Stock or Pricey? Update on Qiagen NV (NASDAQ:QGEN) - CSZ News (NASDAQ:QGEN)
cincysportszone.com - October 14 at 10:13 AM
News IconStock Perspective: Qiagen N.V. (NASDAQ:QGEN) Company Earnings Watch - CSZ News (NASDAQ:QGEN)
cincysportszone.com - October 13 at 7:05 PM
finance.yahoo.com logoQIAGEN's High-Throughput Solutions for Human ID Database (NASDAQ:QGEN)
finance.yahoo.com - October 13 at 10:39 AM
News IconQIAGEN partners with Hamilton Robotics to help law enforcement agencies reduce DNA testing backlogs (NASDAQ:QGEN)
gsnmagazine.com - October 12 at 6:53 PM
4-traders.com logoQIAGEN : Launches High-throughput Solutions for Human ID Databases (NASDAQ:QGEN)
www.4-traders.com - October 12 at 12:23 PM
capitalcube.com logoQIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : October 12, 2016 (NASDAQ:QGEN)
www.capitalcube.com - October 12 at 12:23 PM
News IconConsensus Analyst Feelings for: Qiagen N.V. (NASDAQ:QGEN) , Alibaba Group Holding Limited (NYSE:BABA) - Wall Street Times (press release) (NASDAQ:QGEN)
www.wallstreetnews24.com - October 11 at 7:16 PM
finance.yahoo.com logoQIAGEN N.V. to Report Third Quarter and First Nine Months of 2016 Results (NASDAQ:QGEN)
finance.yahoo.com - October 11 at 7:16 PM
finance.yahoo.com logoQIAGEN Launches QIAsymphony SP Device Outside the U.S. (NASDAQ:QGEN)
finance.yahoo.com - October 11 at 7:16 PM
realistinvestor.com logoQiagen NV (NASDAQ:QGEN) Accounts Payable At $52.306 Millions - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - October 10 at 6:29 PM
publicnow.com logoQIAGEN launches high-throughput solutions for human ID databases (NASDAQ:QGEN)
www.publicnow.com - October 10 at 6:29 PM
investornewswire.com logoCan Qiagen N.V. (NASDAQ:QGEN) Rating Of 2.63 Change In Coming Period? - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - October 8 at 6:26 PM
News IconQiagen N.V. (NASDAQ:QGEN) Updated Broker Price Targets - The ... - The De Soto Edge (NASDAQ:QGEN)
www.desotoedge.com - October 5 at 6:49 PM
finance.yahoo.com logoQIAGEN Introduces QIAsymphony Sample Processing Option to GeneReader NGS Workflow for Non U.S. Customers (NASDAQ:QGEN)
finance.yahoo.com - October 5 at 6:49 PM
News IconThe Key Numbers To Watch From Qiagen NV (NASDAQ:QGEN)'s Earnings - The Voice Registrar (NASDAQ:QGEN)
voiceregistrar.com - October 4 at 6:32 PM
publicnow.com logoQIAGEN and ICMP to develop first NGS workflow for identification of missing persons (NASDAQ:QGEN)
www.publicnow.com - September 29 at 6:50 PM
News IconBroker Roundup For Qiagen N.V. (NASDAQ:QGEN) - The De Soto Edge (NASDAQ:QGEN)
desotoedge.com - September 29 at 12:04 PM
realistinvestor.com logoQiagen N.V. (NASDAQ:QGEN)'s Accounts Payable Is $45.563 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - September 26 at 6:59 PM
investornewswire.com logoQiagen N.V. (NASDAQ:QGEN) Quarterly EPS At $0.32 - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - September 26 at 6:59 PM
News IconCitigroup Inc. Cuts Qiagen NV Price Target to $28.00 (QGEN ... - Petro Global News 24 (NASDAQ:QGEN)
petroglobalnews24.com - September 23 at 11:41 AM
News IconResearch Analysts' Recent Ratings Updates for Qiagen NV (QGEN) - NewsDen (NASDAQ:QGEN)
newsden.net - September 23 at 11:41 AM
nasdaq.com logoQiagen Reaches Analyst Target Price - Nasdaq (NASDAQ:QGEN)
www.nasdaq.com - September 17 at 6:26 PM
realistinvestor.com logoQiagen N.V. (NASDAQ:QGEN) Is Expected To Post EPS Of $0.32 (NASDAQ:QGEN)
www.realistinvestor.com - September 13 at 11:50 AM
streetinsider.com logoQiagen (QGEN) Receives Unfavorable Decision in '537 Patent Suit - StreetInsider.com (NASDAQ:QGEN)
www.streetinsider.com - September 12 at 6:37 PM
realistinvestor.com logoA Price Target Of $25.812 Is Set By Research Analysts For Qiagen N.V. (NASDAQ:QGEN) (NASDAQ:QGEN)
www.realistinvestor.com - September 12 at 11:34 AM
realistinvestor.com logoA Price Target Of $25.812 Is Set By Research Analysts For Qiagen ... - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - September 11 at 6:21 PM
4-traders.com logoQIAGEN : Comments on Preliminary Injunction and Confirms Intention to Defend its U.S. Intellectual Property Position (NASDAQ:QGEN)
www.4-traders.com - September 10 at 6:12 PM
publicnow.com logoQIAGEN comments on preliminary injunction and confirms intention to defend its U.S. intellectual property position (NASDAQ:QGEN)
www.publicnow.com - September 10 at 6:12 PM
News IconStocks Gainers/Losers Roundup- Qiagen NV (NASDAQ:QGEN), Donaldson Firm (NYSE:DCI), Accenture (NYSE:ACN) - Seneca Globe (NASDAQ:QGEN)
www.senecaglobe.com - September 9 at 11:43 AM
publicnow.com logoQIAGEN welcomes U.S. guidance for latent TB testing in primary care (NASDAQ:QGEN)
www.publicnow.com - September 8 at 6:40 PM
realistinvestor.com logoAccounts Payable For Qiagen NV (NASDAQ:QGEN) Is $45.563 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - September 5 at 11:01 AM
investornewswire.com logoCan Shares Of Qiagen N.V. (NASDAQ:QGEN) Get To $27? - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - September 3 at 6:06 PM
realistinvestor.com logoQiagen NV (NASDAQ:QGEN) Is Expected To Post EPS Of $0.32 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - August 31 at 12:09 PM
News IconThe Key Numbers To Watch From Qiagen NV (NASDAQ:QGEN)'s ... - The Voice Registrar (NASDAQ:QGEN)
voiceregistrar.com - August 25 at 12:05 PM
uk.finance.yahoo.com logoBUZZ-European pharma: top fallers on Stoxx 600 amid pricing pressure concern (NASDAQ:QGEN)
uk.finance.yahoo.com - August 25 at 12:05 PM
investornewswire.com logoWill Qiagen N.V. (NASDAQ:QGEN) Hit $27 Price Target? - Investor Newswire (NASDAQ:QGEN)
www.investornewswire.com - August 21 at 10:58 AM
News IconOctal to binary converter Germany stocks lower at close of trade; dax down 1.25% by investing. com convert usd to euro calculator (NASDAQ:QGEN)
getthatmoneyhoney.com - August 20 at 11:02 AM
investing.com logoGermany stocks higher at close of trade; DAX up 0.24% (NASDAQ:QGEN)
www.investing.com - August 15 at 7:25 PM
finance.yahoo.com logo2:05 am Qiagen proposes plans to return ~$250 mln to shareholders; Proposal would adjust capital structure through 4% reduction in number of shares outstanding and direct capital repayment to shareholders (NASDAQ:QGEN)
finance.yahoo.com - August 15 at 9:12 AM


Qiagen NV (NASDAQ:QGEN) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by MarketBeat.com Staff